Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran |
_version_ | 1818864781477543936 |
---|---|
author | Luxmipratha Rajendiran Hanumanthappa Nandeesha Thyagaraju Chitra |
author_facet | Luxmipratha Rajendiran Hanumanthappa Nandeesha Thyagaraju Chitra |
author_sort | Luxmipratha Rajendiran |
collection | DOAJ |
description | Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. Settings and Design: This study was conducted in a tertiary care hospital. Materials and Methods: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. Results: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. Conclusion: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS. |
first_indexed | 2024-12-19T10:37:07Z |
format | Article |
id | doaj.art-618a6c10e36847a1adb218c2766772e1 |
institution | Directory Open Access Journal |
issn | 0974-1208 1998-4766 |
language | English |
last_indexed | 2024-12-19T10:37:07Z |
publishDate | 2021-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Human Reproductive Sciences |
spelling | doaj.art-618a6c10e36847a1adb218c2766772e12022-12-21T20:25:34ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662021-01-0114214414810.4103/jhrs.jhrs_179_20Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndromeLuxmipratha RajendiranHanumanthappa NandeeshaThyagaraju ChitraBackground: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. Settings and Design: This study was conducted in a tertiary care hospital. Materials and Methods: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. Results: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. Conclusion: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiranangiopoietinsclomiphene citrateinterleukinspolycystic ovary syndrome |
spellingShingle | Luxmipratha Rajendiran Hanumanthappa Nandeesha Thyagaraju Chitra Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome Journal of Human Reproductive Sciences angiopoietins clomiphene citrate interleukins polycystic ovary syndrome |
title | Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
title_full | Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
title_fullStr | Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
title_full_unstemmed | Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
title_short | Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
title_sort | reduced angiopoietin 2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
topic | angiopoietins clomiphene citrate interleukins polycystic ovary syndrome |
url | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=144;epage=148;aulast=Rajendiran |
work_keys_str_mv | AT luxmipratharajendiran reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome AT hanumanthappanandeesha reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome AT thyagarajuchitra reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome |